Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients

作者：Nagano Daisuke; Araki Takuya^*; Yanagisawa Kunio; Ogawa Yoshiyuki; Gohda Fumito; Uchiumi Hideki; Handa Hiroshi; Nakamura Tomonori; Yamamoto Koujirou

来源：European Journal of Clinical Pharmacology, 2018, 74(8): 1055-1060.

DOI：10.1007/s00228-018-2464-y

• Darunavir
• Ritonavir
• PBMC
• Intracellular
• Efflux

The clinical efficacies of some antiretroviral drugs are known to not depend on its concentration in blood. To establish a method of dosage adjustment for darunavir (DRV) based on pharmacokinetic theory, we analyzed the correlation between DRV levels in peripheral blood mononuclear cells (PBMCs) and plasma.
The concentrations of DRV and ritonavir (RTV) in plasma and PBMCs of 31 samples obtained from 19 patients were analyzed. An in vitro kinetic study using MOLT-4 cells was performed to assess the contribution of RTV to the intracellular accumulation of DRV.
DRV levels in PBMCs varied between 7.91 and 29.36 ng/10(6) cells (CV 37.5%), while those in plasma were greater. No significant correlation was found between the trough level of DRV in plasma and that in PBMCs (p = 0.575). The inter-day difference in DRV levels in PBMCs seemed smaller than that in plasma (- 41.6-23.0% vs - 83.3-109.1%). In the in vitro study, the elimination half-life of cellular efflux of DRV was 15.7 h in the absence of RTV and extended to 47.6 h in the presence of RTV.
We found a poor correlation between intracellular DRV and plasma DRV levels in patients receiving highly active antiretroviral therapy. The efflux rate of DRV from cells was slow; therefore, the concentration of DRV in PBMCs may reflect average exposure to the drug and clinical efficacy.

• 出版日期2018-8